COLTENE Holding AG

OVERVALUEDCLHLF · OTC · Healthcare
CLHLF·OTC·Healthcare
OVERVALUED
COLTENE Holding AG
19.3%downside
MARKET PRICE
$61.16
FAIR PRICE
$49.33
MARGIN
$11.83
UNDERVALUEDFAIROVERVALUED
P/E RATIO
19.4x
DIV. YIELD
4.93%
ROE
N/A
MARKET CAP
$289M
FPI
fairpriceindex.com

FAIR PRICE VALUATION

19.3%downside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$61.16

FAIR PRICE

$49.33

MARGIN

$11.83

UNDERVALUEDFAIROVERVALUED

P/E Ratio

19.4x

What is P/E? →

Div. Yield

4.93%

ROE

N/A

Market Cap

$289M

Small-cap

NOW AVAILABLE

Get notified when CLHLF's fair price changes

Push notifications when CLHLF's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

4.9/ 10

Low debt levels, but expensive valuation relative to fundamentals and weak profitability margins.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$39.46CONSERVATIVE ENTRY
$49.33FAIR PRICE
$61.16MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$39.46

Fair price × 0.80

DISTANCE

35.5%

Price to entry level

At the current price of $61.16, CLHLF trades 35.5% above the conservative entry level of $39.46. This entry level represents a 20% margin of safety below the calculated fair price of $49.33 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate CLHLF's fair price

COLTENE Holding AG's fair price of $49.33 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $61.16, CLHLF trades 19.3% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting CLHLF's risk profile.

RELATIVE · 30%

Comparing CLHLF's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for CLHLF, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate CLHLF's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for CLHLF.

Explore on Bulios

FAQ

What is the fair price of CLHLF?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for COLTENE Holding AG is $49.33. At the current market price of $61.16, CLHLF trades 19.3% above its calculated fair value.

Is CLHLF overvalued or undervalued?+

COLTENE Holding AG is currently overvalued based on our valuation model. The stock trades at $61.16, which is 19.3% above the fair price of $49.33. The P/E ratio of 19.4x is a key metric in the valuation.

What is the margin of safety for CLHLF?+

With a 20% margin of safety applied to the fair price of $49.33, the conservative entry level for CLHLF is $39.46. At the current market price of $61.16, the stock trades 35.5% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is CLHLF's fair price updated?+

We update fair price calculations for CLHLF daily after market close. The current fair price of $49.33 incorporates the latest market data and sector multiples.

What factors affect CLHLF's fair price calculation?+

CLHLF's fair price of $49.33 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 19.4x, and dividend yield of 4.93%.

Is CLHLF a good buy right now?+

At $61.16, CLHLF trades 19.3% above our fair value estimate of $49.33. The stock is currently overvalued. Fair Price Index provides valuation data — always do your own research before investing.

Does CLHLF pay dividends?+

CLHLF has a dividend yield of 4.93%.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.